Elucidating the role of circNFIB in myocardial fibrosis alleviation by endogenous sulfur dioxide
暂无分享,去创建一个
Jia Liu | Dahai Wang | Yi Lin | Qiuye Zhang | Hong Chang | Ranran Zhang | Chongmin Ren | Shan Gao | N. Nie | Cui Bai
[1] A. Tekkeşin,et al. Prognostic value of serum albumin for long-term mortality in patients with dual-chamber permanent pacemakers. , 2022, Biomarkers in medicine.
[2] Kefei Yuan,et al. CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma , 2022, Molecular Cancer.
[3] A. Tekkeşin,et al. Evaluating systemic immune‐inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction , 2022, Pacing and clinical electrophysiology : PACE.
[4] A. Tekkeşin,et al. The value of C‐reactive protein‐to‐albumin ratio in predicting long‐term mortality among HFrEF patients with implantable cardiac defibrillators , 2021, European journal of clinical investigation.
[5] N. Vaziri,et al. Wnt signaling pathway in aging-related tissue fibrosis and therapies , 2020, Ageing Research Reviews.
[6] A. Durães,et al. Endomyocardial fibrosis: past, present, and future , 2019, Heart Failure Reviews.
[7] H. Costa,et al. Myocardial fibrosis in chagas disease and molecules related to fibrosis , 2019, Parasite immunology.
[8] Cheng Ma,et al. New therapeutic insights into radiation-induced myocardial fibrosis , 2019, Therapeutic advances in chronic disease.
[9] Tingting Yang,et al. Upregulation of Circular RNA CircNFIB Attenuates Cardiac Fibrosis by Sponging miR-433 , 2019, Front. Genet..
[10] C. Tschöpe,et al. Myocardial fibrosis as a matter of cell differentiation: opportunities for new antifibrotic strategies. , 2019, European heart journal.
[11] R. Ardehali,et al. Cardiac fibrosis: potential therapeutic targets. , 2019, Translational research : the journal of laboratory and clinical medicine.
[12] F. Lin,et al. circRNA-miRNA association for coronary heart disease , 2019, Molecular medicine reports.
[13] H. Haybar,et al. Wnt/β-catenin in ischemic myocardium: interactions and signaling pathways as a therapeutic target , 2018, Heart Failure Reviews.
[14] Peili Chen,et al. Sulfur dioxide attenuates sepsis-induced cardiac dysfunction via inhibition of NLRP3 inflammasome activation in rats. , 2018, Nitric oxide : biology and chemistry.
[15] H. Cao,et al. Whole transcriptome sequencing reveals biologically significant RNA markers and related regulating biological pathways in cardiomyocyte hypertrophy induced by high glucose , 2018, Journal of cellular biochemistry.
[16] W. Lei,et al. Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes , 2018, Stem Cell Research & Therapy.
[17] W. Seeger,et al. p38 MAPK Inhibition Improves Heart Function in Pressure‐Loaded Right Ventricular Hypertrophy , 2017, American journal of respiratory cell and molecular biology.
[18] Petar Glažar,et al. A map of human circular RNAs in clinically relevant tissues , 2017, Journal of Molecular Medicine.
[19] F. Rodríguez-Pascual,et al. Myocardial fibrosis in response to pressure overload: elucidating the contribution of tissue transglutaminase. , 2017, Cardiovascular research.
[20] Bing Zhou,et al. A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-β1. , 2017, Biochemical and biophysical research communications.
[21] G. Christensen,et al. Wnt5a is elevated in heart failure and affects cardiac fibroblast function , 2017, Journal of Molecular Medicine.
[22] F. Zannad,et al. Myocardial fibrosis: biomedical research from bench to bedside , 2017, European journal of heart failure.
[23] Sean P. Palecek,et al. Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist , 2017, Proceedings of the National Academy of Sciences.
[24] J. Kjems,et al. Insights into circular RNA biology , 2017, RNA biology.
[25] Xi-Long Zheng,et al. CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts , 2017, Scientific Reports.
[26] Yuan Zhang,et al. The protective role of liquiritin in high fructose-induced myocardial fibrosis via inhibiting NF-κB and MAPK signaling pathway. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[27] Chao-shu Tang,et al. Sulfur Dioxide Protects Against Collagen Accumulation in Pulmonary Artery in Association With Downregulation of the Transforming Growth Factor β1/Smad Pathway in Pulmonary Hypertensive Rats , 2016, Journal of the American Heart Association.
[28] B. Geng,et al. Endogenous sulfur dioxide alleviates collagen remodeling via inhibiting TGF-β/Smad pathway in vascular smooth muscle cells , 2016, Scientific Reports.
[29] Chao-shu Tang,et al. Endogenous Sulfur Dioxide: A New Member of Gasotransmitter Family in the Cardiovascular System , 2015, Oxidative medicine and cellular longevity.
[30] Gregory Y H Lip,et al. Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications. , 2015, Journal of the American College of Cardiology.
[31] Li Yang,et al. Regulation of circRNA biogenesis , 2015, RNA biology.
[32] Hong Tian. Advances in the study on endogenous sulfur dioxide in the cardiovascular system , 2014, Chinese medical journal.
[33] N. Turner,et al. Function and fate of myofibroblasts after myocardial infarction , 2013, Fibrogenesis & tissue repair.
[34] S. Ball,et al. p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts , 2013, Biochemical and biophysical research communications.
[35] Kate S. Carroll,et al. Redox-Sensitive Sulfenic Acid Modification Regulates Surface Expression of the Cardiovascular Voltage-Gated Potassium Channel Kv1.5 , 2012, Circulation research.
[36] N. Turner,et al. Regulation of myocardial matrix metalloproteinase expression and activity by cardiac fibroblasts , 2012, IUBMB life.
[37] Chao-shu Tang,et al. The biological effect of endogenous sulfur dioxide in the cardiovascular system. , 2011, European journal of pharmacology.
[38] Chao-shu Tang,et al. Sulfur dioxide: a novel gaseous signal in the regulation of cardiovascular functions. , 2010, Mini reviews in medicinal chemistry.
[39] N. Frangogiannis,et al. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. , 2010, Journal of molecular and cellular cardiology.
[40] H. Jiang,et al. Differential regulation of collagen types I and III expression in cardiac fibroblasts by AGEs through TRB3/MAPK signaling pathway , 2008, Cellular and Molecular Life Sciences.
[41] B. Geng,et al. Endogenously generated sulfur dioxide and its vasorelaxant effect in rats , 2008, Acta Pharmacologica Sinica.
[42] H. Krum,et al. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. , 2004, Journal of the American College of Cardiology.
[43] Arantxa González,et al. Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease? , 2002, Journal of molecular and cellular cardiology.
[44] V. Petrov,et al. Stimulation of Collagen Production by Transforming Growth Factor-&bgr;1 During Differentiation of Cardiac Fibroblasts to Myofibroblasts , 2002, Hypertension.
[45] D. Jacobsen,et al. Determination of total serum sulfite by HPLC with fluorescence detection. , 1995, Clinical chemistry.
[46] M. Eghbali,et al. Collagen chain mRNAs in isolated heart cells from young and adult rats. , 1988, Journal of molecular and cellular cardiology.
[47] Jianhua Yao,et al. Circular RNAs in Organ Fibrosis. , 2018, Advances in experimental medicine and biology.
[48] J. Hart,et al. Role of sulfur-containing gaseous substances in the cardiovascular system. , 2011, Frontiers in bioscience.
[49] Johan Verjans,et al. Myocardial remodeling after infarction: the role of myofibroblasts , 2010, Nature Reviews Cardiology.
[50] L. Leinwand,et al. Localization of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization. , 1989, Journal of molecular and cellular cardiology.